Infectious disease transmission in solid organ transplantation: Donor evaluation, recipient risk, and outcomes of transmission

Sarah L. White, William Rawlinson, Peter Boan, Vicky Sheppeard, Germaine Wong, Karen Waller, Helen Opdam, John Kaldor, Michael Fink, Deborah Verran, Angela Webster, Kate Wyburn, Lindsay Grayson, Allan Glanville, Nick Cross, Ashley Irish, Toby Coates, Anthony Griffin, Greg Snell, Stephen I. AlexanderScott Campbell, Steven Chadban, Peter Macdonald, Paul Manley, Eva Mehakovic, Vidya Ramachandran, Alicia Mitchell, Michael G Ison

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

In 2016, the Transplantation Society of Australia and New Zealand, with the support of the Australian Government Organ and Tissue authority, commissioned a literature review on the topic of infectious disease transmission from deceased donors to recipients of solid organ transplants. The purpose of this review was to synthesize evidence on transmission risks, diagnostic test characteristics, and recipient management to inform best-practice clinical guidelines. The final review, presented as a special supplement in Transplantation Direct, collates case reports of transmission events and other peer-reviewed literature, and summarizes current (as of June 2017) international guidelines on donor screening and recipient management. Of particular interest at the time of writing was how to maximize utilization of donors at increased risk for transmission of human immunodeficiency virus, hepatitis C virus, and hepatitis B virus, given the recent developments, including the availability of direct-acting antivirals for hepatitis C virus and improvements in donor screening technologies. The review also covers emerging risks associated with recent epidemics (eg, Zika virus) and the risk of transmission of nonendemic pathogens related to donor travel history or country of origin. Lastly, the implications for recipient consent of expanded utilization of donors at increased risk of blood-borne viral disease transmission are considered.

Original languageEnglish (US)
Article numbere416
JournalTransplantation Direct
Volume5
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Infectious Disease Transmission
Organ Transplantation
Tissue Donors
Donor Selection
Practice Guidelines
Hepacivirus
Virus Diseases
New Zealand
Routine Diagnostic Tests
Hepatitis B virus
Antiviral Agents
Transplantation
HIV
Guidelines
Technology
Transplants

ASJC Scopus subject areas

  • Transplantation

Cite this

White, Sarah L. ; Rawlinson, William ; Boan, Peter ; Sheppeard, Vicky ; Wong, Germaine ; Waller, Karen ; Opdam, Helen ; Kaldor, John ; Fink, Michael ; Verran, Deborah ; Webster, Angela ; Wyburn, Kate ; Grayson, Lindsay ; Glanville, Allan ; Cross, Nick ; Irish, Ashley ; Coates, Toby ; Griffin, Anthony ; Snell, Greg ; Alexander, Stephen I. ; Campbell, Scott ; Chadban, Steven ; Macdonald, Peter ; Manley, Paul ; Mehakovic, Eva ; Ramachandran, Vidya ; Mitchell, Alicia ; Ison, Michael G. / Infectious disease transmission in solid organ transplantation : Donor evaluation, recipient risk, and outcomes of transmission. In: Transplantation Direct. 2019 ; Vol. 5, No. 1.
@article{52f484cb3a1a45aaa801cd03f5258b3c,
title = "Infectious disease transmission in solid organ transplantation: Donor evaluation, recipient risk, and outcomes of transmission",
abstract = "In 2016, the Transplantation Society of Australia and New Zealand, with the support of the Australian Government Organ and Tissue authority, commissioned a literature review on the topic of infectious disease transmission from deceased donors to recipients of solid organ transplants. The purpose of this review was to synthesize evidence on transmission risks, diagnostic test characteristics, and recipient management to inform best-practice clinical guidelines. The final review, presented as a special supplement in Transplantation Direct, collates case reports of transmission events and other peer-reviewed literature, and summarizes current (as of June 2017) international guidelines on donor screening and recipient management. Of particular interest at the time of writing was how to maximize utilization of donors at increased risk for transmission of human immunodeficiency virus, hepatitis C virus, and hepatitis B virus, given the recent developments, including the availability of direct-acting antivirals for hepatitis C virus and improvements in donor screening technologies. The review also covers emerging risks associated with recent epidemics (eg, Zika virus) and the risk of transmission of nonendemic pathogens related to donor travel history or country of origin. Lastly, the implications for recipient consent of expanded utilization of donors at increased risk of blood-borne viral disease transmission are considered.",
author = "White, {Sarah L.} and William Rawlinson and Peter Boan and Vicky Sheppeard and Germaine Wong and Karen Waller and Helen Opdam and John Kaldor and Michael Fink and Deborah Verran and Angela Webster and Kate Wyburn and Lindsay Grayson and Allan Glanville and Nick Cross and Ashley Irish and Toby Coates and Anthony Griffin and Greg Snell and Alexander, {Stephen I.} and Scott Campbell and Steven Chadban and Peter Macdonald and Paul Manley and Eva Mehakovic and Vidya Ramachandran and Alicia Mitchell and Ison, {Michael G}",
year = "2019",
month = "1",
day = "1",
doi = "10.1097/TXD.0000000000000852",
language = "English (US)",
volume = "5",
journal = "Transplantation Direct",
issn = "2373-8731",
publisher = "Wolters Kluwer Health",
number = "1",

}

White, SL, Rawlinson, W, Boan, P, Sheppeard, V, Wong, G, Waller, K, Opdam, H, Kaldor, J, Fink, M, Verran, D, Webster, A, Wyburn, K, Grayson, L, Glanville, A, Cross, N, Irish, A, Coates, T, Griffin, A, Snell, G, Alexander, SI, Campbell, S, Chadban, S, Macdonald, P, Manley, P, Mehakovic, E, Ramachandran, V, Mitchell, A & Ison, MG 2019, 'Infectious disease transmission in solid organ transplantation: Donor evaluation, recipient risk, and outcomes of transmission', Transplantation Direct, vol. 5, no. 1, e416. https://doi.org/10.1097/TXD.0000000000000852

Infectious disease transmission in solid organ transplantation : Donor evaluation, recipient risk, and outcomes of transmission. / White, Sarah L.; Rawlinson, William; Boan, Peter; Sheppeard, Vicky; Wong, Germaine; Waller, Karen; Opdam, Helen; Kaldor, John; Fink, Michael; Verran, Deborah; Webster, Angela; Wyburn, Kate; Grayson, Lindsay; Glanville, Allan; Cross, Nick; Irish, Ashley; Coates, Toby; Griffin, Anthony; Snell, Greg; Alexander, Stephen I.; Campbell, Scott; Chadban, Steven; Macdonald, Peter; Manley, Paul; Mehakovic, Eva; Ramachandran, Vidya; Mitchell, Alicia; Ison, Michael G.

In: Transplantation Direct, Vol. 5, No. 1, e416, 01.01.2019.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Infectious disease transmission in solid organ transplantation

T2 - Donor evaluation, recipient risk, and outcomes of transmission

AU - White, Sarah L.

AU - Rawlinson, William

AU - Boan, Peter

AU - Sheppeard, Vicky

AU - Wong, Germaine

AU - Waller, Karen

AU - Opdam, Helen

AU - Kaldor, John

AU - Fink, Michael

AU - Verran, Deborah

AU - Webster, Angela

AU - Wyburn, Kate

AU - Grayson, Lindsay

AU - Glanville, Allan

AU - Cross, Nick

AU - Irish, Ashley

AU - Coates, Toby

AU - Griffin, Anthony

AU - Snell, Greg

AU - Alexander, Stephen I.

AU - Campbell, Scott

AU - Chadban, Steven

AU - Macdonald, Peter

AU - Manley, Paul

AU - Mehakovic, Eva

AU - Ramachandran, Vidya

AU - Mitchell, Alicia

AU - Ison, Michael G

PY - 2019/1/1

Y1 - 2019/1/1

N2 - In 2016, the Transplantation Society of Australia and New Zealand, with the support of the Australian Government Organ and Tissue authority, commissioned a literature review on the topic of infectious disease transmission from deceased donors to recipients of solid organ transplants. The purpose of this review was to synthesize evidence on transmission risks, diagnostic test characteristics, and recipient management to inform best-practice clinical guidelines. The final review, presented as a special supplement in Transplantation Direct, collates case reports of transmission events and other peer-reviewed literature, and summarizes current (as of June 2017) international guidelines on donor screening and recipient management. Of particular interest at the time of writing was how to maximize utilization of donors at increased risk for transmission of human immunodeficiency virus, hepatitis C virus, and hepatitis B virus, given the recent developments, including the availability of direct-acting antivirals for hepatitis C virus and improvements in donor screening technologies. The review also covers emerging risks associated with recent epidemics (eg, Zika virus) and the risk of transmission of nonendemic pathogens related to donor travel history or country of origin. Lastly, the implications for recipient consent of expanded utilization of donors at increased risk of blood-borne viral disease transmission are considered.

AB - In 2016, the Transplantation Society of Australia and New Zealand, with the support of the Australian Government Organ and Tissue authority, commissioned a literature review on the topic of infectious disease transmission from deceased donors to recipients of solid organ transplants. The purpose of this review was to synthesize evidence on transmission risks, diagnostic test characteristics, and recipient management to inform best-practice clinical guidelines. The final review, presented as a special supplement in Transplantation Direct, collates case reports of transmission events and other peer-reviewed literature, and summarizes current (as of June 2017) international guidelines on donor screening and recipient management. Of particular interest at the time of writing was how to maximize utilization of donors at increased risk for transmission of human immunodeficiency virus, hepatitis C virus, and hepatitis B virus, given the recent developments, including the availability of direct-acting antivirals for hepatitis C virus and improvements in donor screening technologies. The review also covers emerging risks associated with recent epidemics (eg, Zika virus) and the risk of transmission of nonendemic pathogens related to donor travel history or country of origin. Lastly, the implications for recipient consent of expanded utilization of donors at increased risk of blood-borne viral disease transmission are considered.

UR - http://www.scopus.com/inward/record.url?scp=85064169195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064169195&partnerID=8YFLogxK

U2 - 10.1097/TXD.0000000000000852

DO - 10.1097/TXD.0000000000000852

M3 - Review article

C2 - 30656214

AN - SCOPUS:85064169195

VL - 5

JO - Transplantation Direct

JF - Transplantation Direct

SN - 2373-8731

IS - 1

M1 - e416

ER -